Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carnitine Supplementation in Children with Drug Resistant Epilepsy on Ketogenic Diet
NCT06198803Phase 1Unknown
- Sponsor
- Ain Shams University
- Start
- Jan 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levocarnitine in epilepsy (2 arms), sponsored by Ain Shams University. Primary endpoints: Systolic and Diastolic Functions at 6 months, Serum Triglycerides, Cholesterol, LDL, and HDL at 6 months and 1 more. Status: unknown.
02
Drugs
levocarnitine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT06198803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06198803.